BIOA Smart Money
BioAge Labs Inc.
1W: -1.6%
1M: -23.8%
3M: -75.3%
YTD: -57.4%
1Y: -28.0%
$5.47
+0.48 (+9.62%)
Weekly Expected Move ±10.0%
$4
$5
$5
$6
$6
Credit Risk of going bust: higher than 72% of companies Debt: 1.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 99.7%), BioAge Labs Inc. would be worth roughly what it owes.
Total debt $2.8M against a stock market value of $205.9M.
Distance to default 3.26 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 129.6%; Altman Z'' 18.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.02 (down 99.7%), BioAge Labs Inc. would be worth roughly what it owes.
Total debt $2.8M against a stock market value of $205.9M.
Distance to default 3.26 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $1.4M (short-term plus half of long-term), stock volatility 129.6%; Altman Z'' 18.29. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026172
Institutions Holding
+12 vs prior
449.3%
Ownership
+161.79%
31
New
61
Increased
57
Reduced
19
Closed
👔 Insider Trades
14 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Barton Shane | officer: principal accounting officer | S-Sale | 20,216 | $25.19 | $509K | Filing |
| 2026-06-29 | Barton Shane | officer: principal accounting officer | S-Sale | 42,350 | $25.21 | $1.1M | Filing |
| 2026-03-02 | RUBIN PAUL D | officer: chief medical officer | S-Sale | 7,433 | $20.30 | $151K | Filing |
| 2026-02-02 | RUBIN PAUL D | officer: chief medical officer | S-Sale | 7,433 | $18.75 | $139K | Filing |
| 2026-01-13 | GOLDSTEIN DOV A MD | officer: chief financial officer | S-Sale | 8,974 | $18.43 | $165K | Filing |
| 2026-01-13 | GOLDSTEIN DOV A MD | officer: chief financial officer | S-Sale | 4,440 | $19.45 | $86K | Filing |
| 2026-01-13 | GOLDSTEIN DOV A MD | officer: chief financial officer | S-Sale | 11,663 | $20.54 | $240K | Filing |
| 2026-01-13 | GOLDSTEIN DOV A MD | officer: chief financial officer | S-Sale | 1,923 | $21.08 | $41K | Filing |
| 2026-01-13 | Fortney Kristen | officer: chief executive officer | S-Sale | 233,107 | $18.12 | $4.2M | Filing |
| 2026-01-02 | RUBIN PAUL D | officer: chief medical officer | S-Sale | 7,433 | $12.85 | $95K | Filing |
| 2025-12-09 | RUBIN PAUL D | officer: chief medical officer | S-Sale | 18,000 | $12.00 | $216K | Filing |
| 2025-12-04 | RUBIN PAUL D | officer: chief medical officer | S-Sale | 68,897 | $10.19 | $702K | Filing |
| 2024-09-27 | Barton Shane | officer: principal accounting officer | P-Purchase | 2,632 | $18.00 | $47K | Filing |
| 2024-09-27 | Hemrajani Rekha | director | P-Purchase | 3,000 | $18.00 | $54K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 3,233,170 | $79M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 2,849,077 | $70M | +581,321 | 2026-06-30 | Filing |
| Cormorant Asset Management, LP | 2,390,605 | $59M | -500,000 | 2026-06-30 | Filing |
| Sofinnova Investments, Inc. | 2,293,788 | $56M | — | 2026-06-30 | Filing |
| Jupiter Topco LLC | 2,144,633 | $53M | +2,144,633 | 2026-06-30 | Filing |
| Octagon Capital Advisors LP | 1,748,000 | $43M | — | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 1,671,648 | $41M | +21,000 | 2026-06-30 | Filing |
| MPM BIOIMPACT LLC | 1,667,661 | $41M | +1,667,661 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,544,214 | $38M | +189,308 | 2026-06-30 | Filing |
| Polar Capital Holdings Plc | 1,072,344 | $26M | -60,296 | 2026-06-30 | Filing |
| BRAIDWELL LP | 1,033,129 | $25M | -167,458 | 2026-06-30 | Filing |
| STATE STREET CORP | 1,021,464 | $25M | +170,570 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,004,264 | $25M | +254,998 | 2026-06-30 | Filing |
| Sands Capital Alternatives, LLC | 786,353 | $19M | — | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 752,153 | $18M | +40,342 | 2026-06-30 | Filing |
| D. E. Shaw & Co., Inc. | 742,761 | $18M | +43,571 | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 702,858 | $17M | -624,687 | 2026-06-30 | Filing |
| Pivotal bioVenture Partners Investment A | 653,374 | $16M | — | 2026-06-30 | Filing |
| COSMIC MANAGEMENT, LLC | 501,833 | $12M | — | 2026-06-30 | Filing |
| STEMPOINT CAPITAL LP | 464,171 | $11M | +125,517 | 2026-06-30 | Filing |